BioSpace News Archive

Spero Therapeutics, Inc. today announced financial results for the fourth quarter and full-year ended December 31, 2019 and provided a pipeline update.

Diamond Equity Research, an equity research firm with a focus on micro capitalization and small capitalization public companies has released a comprehensive update note of Hoth Therapeutics, Inc..

Medical Home Network’s community-based care teams proactively reach out to high risk individuals to offer help

NuProbe Global, a global molecular diagnostics company based in Shanghai and Suzhou, China and Houston, TX, today announced it has entered into a collaboration agreement with QIAGEN to develop next-generation sequencing (NGS)-based cancer diagnostic tests for non-invasive liquid biopsy.

Kaiser Permanente is providing $1 million to increase capacity for preventing and treating cases of COVID-19, the disease caused by the novel coronavirus, within the nation’s homeless population in a collaboration with the National Health Care for the Homeless Council.

Celavet has previously collaborated with Dr. Watts to evaluate OK100 stem cells for treatment of equine tendon injuries

Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that it has completed the non-cash transaction of the transition of Oncometrix’s customer base, as discussed in Precipio’s recent announcement.

Jvion, a leader in clinical AI, announced that it has initiated a data analysis project to identify patterns tied to the spread of viruses similar to COVID-19 that cause acute respiratory illness.

Mango Sciences, Inc., a leading data science company focused on emerging markets, today announced how it plans to understand, manage, and solve the health challenges of underrepresented populations to enable precision medicine for billions of consumers.

Olympus, a global technology leader in designing and delivering innovative solutions for medical procedures, among other core businesses, announced today that an updated guidance from the Food and Drug Administration (FDA) mandates that laparoscopic power morcellation in gynecological procedures be conducted with an approved containment device.